Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-9255
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies ; volume:17 ; number:1 ; day:21 ; month:4 ; year:2020 ; pages:1-8 ; date:12.2020
Journal of Inflammation ; 17, Heft 1 (21.4.2020), 1-8, 12.2020
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Kaur, Amandip
Goggolidou, Paraskevi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12950-020-00246-4
- URN
-
urn:nbn:de:101:1-2020070300123652448870
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kaur, Amandip
- Goggolidou, Paraskevi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Factors influencing the discontinuation of biologic therapies in patients with ulcerative colitis
Ulcerative colitis - Crohn's disease
Ulcerative Colitis: Shifting Sands
Specific immunotherapy ameliorates ulcerative colitis
Appendiceal mucocele in ulcerative colitis
Could Mycobacterium avium subspecies paratuberculosis cause Crohn’s disease, ulcerative colitis…and colorectal cancer?
Listeria monocytogenes sepsis in ulcerative colitis
Immunophenotyping of patients with ulcerative colitis
Cerebral venous thrombosis in ulcerative colitis
Ozanimod: A Review in Ulcerative Colitis
Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis
Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitis
Factors influencing the discontinuation of biologic therapies in patients with ulcerative colitis
Ulcerative colitis - Crohn's disease
Ulcerative Colitis: Shifting Sands
Specific immunotherapy ameliorates ulcerative colitis
Appendiceal mucocele in ulcerative colitis
Could Mycobacterium avium subspecies paratuberculosis cause Crohn’s disease, ulcerative colitis…and colorectal cancer?
Listeria monocytogenes sepsis in ulcerative colitis
Immunophenotyping of patients with ulcerative colitis
Cerebral venous thrombosis in ulcerative colitis
Ozanimod: A Review in Ulcerative Colitis
Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis
Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitis
Factors influencing the discontinuation of biologic therapies in patients with ulcerative colitis
Ulcerative colitis - Crohn's disease
Ulcerative Colitis: Shifting Sands
Specific immunotherapy ameliorates ulcerative colitis
Appendiceal mucocele in ulcerative colitis
Could Mycobacterium avium subspecies paratuberculosis cause Crohn’s disease, ulcerative colitis…and colorectal cancer?
Listeria monocytogenes sepsis in ulcerative colitis
Immunophenotyping of patients with ulcerative colitis
Cerebral venous thrombosis in ulcerative colitis
Ozanimod: A Review in Ulcerative Colitis
Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis